BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9065459)

  • 1. The domain architecture of cytochrome P450BM-3.
    Govindaraj S; Poulos TL
    J Biol Chem; 1997 Mar; 272(12):7915-21. PubMed ID: 9065459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-domain interaction in cytochrome P450BM-3.
    Sevrioukova I; Peterson JA
    Biochimie; 1996; 78(8-9):744-51. PubMed ID: 9010603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3.
    Klein ML; Fulco AJ
    J Biol Chem; 1993 Apr; 268(10):7553-61. PubMed ID: 8463285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3.
    Govindaraj S; Poulos TL
    Biochemistry; 1995 Sep; 34(35):11221-6. PubMed ID: 7669780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron transfer between the FMN and heme domains of cytochrome P450BM-3. Effects of substrate and CO.
    Hazzard JT; Govindaraj S; Poulos TL; Tollin G
    J Biol Chem; 1997 Mar; 272(12):7922-6. PubMed ID: 9065460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
    Sevrioukova I; Truan G; Peterson JA
    Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
    Sevrioukova I; Truan G; Peterson JA
    Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis.
    Govindaraj S; Poulos TL
    Protein Sci; 1996 Jul; 5(7):1389-93. PubMed ID: 8819171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P450BM-3; a tale of two domains--or is it three?
    Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
    Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
    Chen HC; Swenson RP
    Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
    Gonvindaraj S; Li H; Poulos TL
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
    Haines DC; Sevrioukova IF; Peterson JA
    Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
    Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P450BM-3: reduction by NADPH and sodium dithionite.
    Peterson JA; Boddupalli SS
    Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a cytochrome P450-redox partner electron-transfer complex.
    Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FMN to heme electron transfer in cytochrome P450BM-3. Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site.
    Sevrioukova IF; Hazzard JT; Tollin G; Poulos TL
    J Biol Chem; 1999 Dec; 274(51):36097-106. PubMed ID: 10593892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
    Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
    J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.